Catecholaminergic polymorphic ventricular tachycardia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
===Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of [[syncope]], [[sudden cardiac death]], and [[ventricular tachycardia]]===
===Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of [[syncope]], [[sudden cardiac death]], and [[ventricular tachycardia]]===


On the basis [[syncope]], [[sudden cardiac death]], and [[ventricular tachycardia]], Catecholaminergic polymorphic ventricular tachycardia must be differentiated from [[Arrhythmogenic right ventricular dysplasia]], Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [[TdP]]), [[Long QT syndrome]], [[Andersen-Tawil syndrome]] and [[Brugada syndrome]].
On the basis [[syncope]], [[sudden cardiac death]], and [[ventricular tachycardia]], Catecholaminergic polymorphic ventricular tachycardia must be differentiated from [[Arrhythmogenic right ventricular dysplasia]], Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [[TdP]]), [[Long QT syndrome]], [[Andersen-Tawil syndrome]] and [[Brugada syndrome]].<ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1289/ |title=Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}<ref/>
{| class="wikitable sortable"
{| class="wikitable sortable"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
Line 49: Line 49:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arrhythmogenic right ventricular dysplasia]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arrhythmogenic right ventricular dysplasia]]
| style="background: #F5F5F5; padding: 5px;" |Usually caused by [[mutations]] in [[genes]] encoding for [[desmosomal proteins]].
| style="background: #F5F5F5; padding: 5px;" |Usually caused by [[mutations]] in [[genes]] encoding for [[desmosomal proteins]].<ref name="BassoCorrado2009">{{cite journal|last1=Basso|first1=Cristina|last2=Corrado|first2=Domenico|last3=Marcus|first3=Frank I|last4=Nava|first4=Andrea|last5=Thiene|first5=Gaetano|title=Arrhythmogenic right ventricular cardiomyopathy|journal=The Lancet|volume=373|issue=9671|year=2009|pages=1289–1300|issn=01406736|doi=10.1016/S0140-6736(09)60256-7}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Symptoms are usually exercise-related
| style="background: #F5F5F5; padding: 5px;" |Symptoms are usually exercise-related


Line 62: Line 62:
* [[Right bundle branch bloc]]k.
* [[Right bundle branch bloc]]k.
| style="background: #F5F5F5; padding: 5px;" |[[Left bundle branch block]] pattern during [[tachycardia]]
| style="background: #F5F5F5; padding: 5px;" |[[Left bundle branch block]] pattern during [[tachycardia]]
| style="background: #F5F5F5; padding: 5px;" |It primarily affects the right [[ventricle]] (RV). Changes seen are:
| style="background: #F5F5F5; padding: 5px;" |It primarily affects the right [[ventricle]] (RV). Changes seen are:<ref name="HundleyBluemke2010">{{cite journal|last1=Hundley|first1=W. Gregory|last2=Bluemke|first2=David A.|last3=Finn|first3=J. Paul|last4=Flamm|first4=Scott D.|last5=Fogel|first5=Mark A.|last6=Friedrich|first6=Matthias G.|last7=Ho|first7=Vincent B.|last8=Jerosch-Herold|first8=Michael|last9=Kramer|first9=Christopher M.|last10=Manning|first10=Warren J.|last11=Patel|first11=Manesh|last12=Pohost|first12=Gerald M.|last13=Stillman|first13=Arthur E.|last14=White|first14=Richard D.|last15=Woodard|first15=Pamela K.|title=ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance|journal=Circulation|volume=121|issue=22|year=2010|pages=2462–2508|issn=0009-7322|doi=10.1161/CIR.0b013e3181d44a8f}}</ref>


* Fatty infiltration of the RV free wall
* Fatty infiltration of the RV free wall
Line 156: Line 156:
(SC-[[torsade de pointes]] [[TdP]])
(SC-[[torsade de pointes]] [[TdP]])
| style="background: #F5F5F5; padding: 5px;" |Unknown
| style="background: #F5F5F5; padding: 5px;" |Unknown
| style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic stimuli
| style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic stimuli,{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1289/ |title=Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}


* [[Syncope]]
* [[Syncope]]

Revision as of 09:20, 30 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]

Overview

Catecholaminergic polymorphic ventricular tachycardia must be differentiated from Arrhythmogenic right ventricular dysplasia, Short-coupled ventricular tachycardia (SC-torsade de pointes [TdP]), Long QT syndrome and Andersen-Tawil syndrome.

Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases

Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause syncope, ventricular tachycardia, and sudden cardiac death, such as:

Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of syncope, sudden cardiac death, and ventricular tachycardia

On the basis syncope, sudden cardiac death, and ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia must be differentiated from Arrhythmogenic right ventricular dysplasia, Short-coupled ventricular tachycardia (SC-torsade de pointes TdP), Long QT syndrome, Andersen-Tawil syndrome and Brugada syndrome. | style="background: #F5F5F5; padding: 5px;" |Symptoms are usually exercise-related

Symptoms and signs related to right ventricular failure may also be seen. | style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" |Left bundle branch block pattern during tachycardia | style="background: #F5F5F5; padding: 5px;" |It primarily affects the right ventricle (RV). Changes seen are:[1]

  • Fatty infiltration of the RV free wall
  • Thinning of the RV myocardium
  • RV Dilation and Regional Wall Motion Abnormalities

|- | style="background: #DCDCDC; padding: 5px; text-align: center;" |Short QT syndrome | style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" |Symptoms are not exercise-related or triggered

Physical examination is normal. | style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" | - | style="background: #F5F5F5; padding: 5px;" | - |- | style="background: #DCDCDC; padding: 5px; text-align: center;" |Long QT syndrome | style="background: #F5F5F5; padding: 5px;" |Mutations in genes encoding for sodium and potassium ion channels in the heart. | style="background: #F5F5F5; padding: 5px;" |Symptoms are triggered by exercise, stress, certain drugs, etc

| style="background: #F5F5F5; padding: 5px;" |

  • Prolongation of the QTc interval (>460 ms)
  • Abnormal T-wave morphology

| style="background: #F5F5F5; padding: 5px;" |

  • Prolongation of the QTc interval (>460 ms)
  • Abnormal T-wave morphology

| style="background: #F5F5F5; padding: 5px;" |- |- | style="background: #DCDCDC; padding: 5px; text-align: center;" |Andersen-Tawil syndrome | style="background: #F5F5F5; padding: 5px;" |Mutation in KCNJ2 gene. | style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic activation

Other significant findings include:

| style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" |- | style="background: #F5F5F5; padding: 5px;" |- |- | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brugada syndrome | style="background: #F5F5F5; padding: 5px;" |Mutation in SCN5A gene. | style="background: #F5F5F5; padding: 5px;" |Symptoms occur predominantly during sleep or at rest

Other findings:

| style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" |- | style="background: #F5F5F5; padding: 5px;" |- |- | style="background: #DCDCDC; padding: 5px; text-align: center;" |Short-coupled ventricular tachycardia (SC-torsade de pointes TdP) | style="background: #F5F5F5; padding: 5px;" |Unknown | style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic stimuli,"Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf".

| style="background: #F5F5F5; padding: 5px;" |

| style="background: #F5F5F5; padding: 5px;" |- | style="background: #F5F5F5; padding: 5px;" |- |}

References

  1. Hundley, W. Gregory; Bluemke, David A.; Finn, J. Paul; Flamm, Scott D.; Fogel, Mark A.; Friedrich, Matthias G.; Ho, Vincent B.; Jerosch-Herold, Michael; Kramer, Christopher M.; Manning, Warren J.; Patel, Manesh; Pohost, Gerald M.; Stillman, Arthur E.; White, Richard D.; Woodard, Pamela K. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance". Circulation. 121 (22): 2462–2508. doi:10.1161/CIR.0b013e3181d44a8f. ISSN 0009-7322.

Template:WH Template:WS